US5889169A
(en)
*
|
1991-05-16 |
1999-03-30 |
Cold Spring Harbor Laboratory |
Cell cycle regulatory protein p16 gene
|
US7550561B1
(en)
|
1991-05-16 |
2009-06-23 |
Cold Spring Harbor Laboratory |
p16INK4 polypeptides
|
AU735667B2
(en)
*
|
1991-06-05 |
2001-07-12 |
Board Of Regents Acting For And On Behalf Of The University Of Michigan, The |
Targeted delivery of genes encoding secretory proteins
|
NZ244306A
(en)
*
|
1991-09-30 |
1995-07-26 |
Boehringer Ingelheim Int |
Composition for introducing nucleic acid complexes into eucaryotic cells, complex containing nucleic acid and endosomolytic agent, peptide with endosomolytic domain and nucleic acid binding domain and preparation
|
US5981273A
(en)
*
|
1991-09-30 |
1999-11-09 |
Boehringer Ingelheim Int'l. Gmbh |
Composition comprising an endosomolytic agent for introducing nucleic acid complexes into higher eucaryotic cells
|
US5521291A
(en)
*
|
1991-09-30 |
1996-05-28 |
Boehringer Ingelheim International, Gmbh |
Conjugates for introducing nucleic acid into higher eucaryotic cells
|
US5922859A
(en)
*
|
1992-02-01 |
1999-07-13 |
Boehringer Ingelheim International Gmbh |
Complexes containing nucleic acid which can be taken-up by endocytosis into higher eukaryotic cells
|
US5656609A
(en)
*
|
1992-09-24 |
1997-08-12 |
University Of Connecticut |
Method of enhancing and/or prolonging expression of gene introduced into a cell using colchicine
|
US6211334B1
(en)
|
1992-10-16 |
2001-04-03 |
Cold Spring Harbor |
Cell-cycle regulatory proteins, and uses related thereto
|
US5962316A
(en)
*
|
1992-10-16 |
1999-10-05 |
Cold Spring Harbor Laboratory |
Cell-cycle regulatory proteins, and uses related thereto
|
AU688292B2
(en)
*
|
1992-11-09 |
1998-03-12 |
United States Government as represented by the Department of Health and Human Services, The |
Targetable vector particles
|
US6043030A
(en)
*
|
1992-12-17 |
2000-03-28 |
Cold Spring Harbor Laboratory |
Cell-cycle regulatory proteins, and uses related thereto
|
US6331390B1
(en)
|
1992-12-17 |
2001-12-18 |
Cold Spring Harbor Laboratory |
Cell-cycle regulatory proteins, and uses related thereto
|
EP1770168A3
(en)
*
|
1993-01-26 |
2009-05-06 |
The Trustees of the University of Pennsylvania (a corporation of Pennsylvania) |
Compositions and methods for delivery of genetic material
|
ATE302854T1
(de)
*
|
1993-01-26 |
2005-09-15 |
Univ Pennsylvania |
Zusammensetzungen und verfahren zur verabreichung von genetischem material
|
US7001759B1
(en)
|
1993-01-26 |
2006-02-21 |
The Trustees Of The University Of Pennsylvania |
Compositions and methods for delivery of genetic material
|
US7691632B2
(en)
|
1993-11-18 |
2010-04-06 |
Cold Spring Harbor Laboratory |
Kit for detecting the level of cyclin-dependent kinase inhibitor P16 gene expression
|
US5728399A
(en)
*
|
1994-06-29 |
1998-03-17 |
University Of Conn. |
Use of a bacterial component to enhance targeted delivery of polynucleotides to cells
|
WO1996021036A2
(en)
*
|
1994-12-30 |
1996-07-11 |
Chiron Viagene, Inc. |
Nucleic acid condensing agents with reduced immunogenicity
|
US6019980A
(en)
*
|
1995-06-07 |
2000-02-01 |
Connaught Laboratories Limited |
Nucleic acid respiratory syncytial virus vaccines
|
US5823453A
(en)
*
|
1995-11-14 |
1998-10-20 |
J & L Fiber Services, Inc. |
Refiner disc with curved refiner bars
|
US7888466B2
(en)
|
1996-01-11 |
2011-02-15 |
Human Genome Sciences, Inc. |
Human G-protein chemokine receptor HSATU68
|
WO1998055611A1
(en)
*
|
1997-06-06 |
1998-12-10 |
Regents Of The University Of Michigan |
Neuregulin response element and uses therefor
|
NZ528767A
(en)
|
1998-03-30 |
2005-08-26 |
Northwest Biotherapeutics Inc |
Therapeutic and diagnostic applications based on the role of the CXCR-4 gene in tumorigenesis
|
CN1163602C
(zh)
|
1998-04-07 |
2004-08-25 |
科里克萨公司 |
结核杆菌抗原融合蛋白及其应用
|
US7078483B2
(en)
|
1998-04-29 |
2006-07-18 |
University Of Southern California |
Retroviral vectors including modified envelope escort proteins
|
WO2000050620A2
(en)
|
1999-02-26 |
2000-08-31 |
Human Genome Sciences, Inc. |
Human endokine alpha and methods of use
|
US6759393B1
(en)
|
1999-04-12 |
2004-07-06 |
Pfizer Inc. |
Growth hormone and growth hormone releasing hormone compositions
|
US7566452B1
(en)
|
1999-05-04 |
2009-07-28 |
New York University |
Cancer treatment with endothelin receptor antagonists
|
WO2000069898A2
(en)
|
1999-05-14 |
2000-11-23 |
Arbor Vita Corporation |
Molecular interactions in allergy cells
|
ATE364689T1
(de)
|
1999-11-18 |
2007-07-15 |
Dendreon Corp |
Nukleinsäuren, welche für endotheliasen kodieren, endotheliasen, sowie deren verwendung
|
EP2210948A3
(en)
|
1999-12-10 |
2010-10-06 |
Life Technologies Corporation |
Use of multiple recombination sites with unique specificity in recombinational cloning
|
US7700341B2
(en)
|
2000-02-03 |
2010-04-20 |
Dendreon Corporation |
Nucleic acid molecules encoding transmembrane serine proteases, the encoded proteins and methods based thereon
|
EP1294949A4
(en)
|
2000-06-15 |
2004-08-25 |
Human Genome Sciences Inc |
HUMAN TUMORNESCROSE FACTOR DELTA AND EPSILON
|
WO2002002641A1
(en)
|
2000-06-16 |
2002-01-10 |
Human Genome Sciences, Inc. |
Antibodies that immunospecifically bind to blys
|
EP1967205B1
(en)
|
2000-08-30 |
2012-10-10 |
Pfizer Products Inc. |
Anti-IgE vaccines
|
US20040018194A1
(en)
|
2000-11-28 |
2004-01-29 |
Francisco Joseph A. |
Recombinant anti-CD30 antibodies and uses thereof
|
CA2430039C
(en)
|
2000-11-28 |
2014-01-28 |
Medimmune, Inc. |
Methods of administering/dosing anti-rsv antibodies for prophylaxis and treatment
|
WO2002060919A2
(en)
|
2000-12-12 |
2002-08-08 |
Medimmune, Inc. |
Molecules with extended half-lives, compositions and uses thereof
|
US8231878B2
(en)
|
2001-03-20 |
2012-07-31 |
Cosmo Research & Development S.P.A. |
Receptor trem (triggering receptor expressed on myeloid cells) and uses thereof
|
US8981061B2
(en)
|
2001-03-20 |
2015-03-17 |
Novo Nordisk A/S |
Receptor TREM (triggering receptor expressed on myeloid cells) and uses thereof
|
US7176300B2
(en)
|
2001-03-30 |
2007-02-13 |
Avigenics, Inc. |
Avian lysozyme promoter
|
US7541512B2
(en)
|
2001-03-30 |
2009-06-02 |
Synageva Biopharma Corp. |
Avians containing a lysozyme promoter transgene
|
AU2002255995A1
(en)
|
2001-03-30 |
2002-10-15 |
Avigenics, Inc. |
Avian lysozyme promoter
|
DE60236646D1
(de)
|
2001-04-13 |
2010-07-22 |
Human Genome Sciences Inc |
Anti-VEGF-2 Antikörper
|
FI116851B
(fi)
|
2001-05-03 |
2006-03-15 |
Fit Biotech Oyj Plc |
Ilmentämisvektori, sen käyttöjä ja menetelmä sen valmistamiseksi sekä sitä sisältäviä tuotteita
|
JP2003047482A
(ja)
|
2001-05-22 |
2003-02-18 |
Pfizer Prod Inc |
非アナフィラキシー誘発性IgEワクチン
|
DK1572874T3
(da)
|
2001-05-25 |
2013-12-16 |
Human Genome Sciences Inc |
Antistoffer, der immunospecifikt binder til TRAIL receptorer
|
GB0113552D0
(en)
*
|
2001-06-05 |
2001-07-25 |
Secr Defence |
Vaccines
|
EP1404842A2
(en)
|
2001-06-29 |
2004-04-07 |
Novartis AG |
Perv screening method and use thereof
|
US20030138434A1
(en)
*
|
2001-08-13 |
2003-07-24 |
Campbell Robert L. |
Agents for enhancing the immune response
|
US7550650B2
(en)
|
2001-09-18 |
2009-06-23 |
Synageva Biopharma Corp. |
Production of a transgenic avian by cytoplasmic injection
|
US7335761B2
(en)
|
2001-11-30 |
2008-02-26 |
Avigenics, Inc. |
Avian gene expression controlling regions
|
US7294507B2
(en)
|
2001-11-30 |
2007-11-13 |
Avigenics, Inc. |
Ovomucoid promoters and methods of use
|
US6875588B2
(en)
|
2001-11-30 |
2005-04-05 |
Avigenics, Inc. |
Ovomucoid promoter and methods of use
|
US20060084056A1
(en)
|
2002-02-13 |
2006-04-20 |
Nadia Harbeck |
Methods for selecting treatment regimens and predicting outcomes in cancer patients
|
US7135562B2
(en)
|
2002-03-14 |
2006-11-14 |
University Of Cincinnati |
Avian iFABP gene expression controlling region
|
AU2003226065B2
(en)
|
2002-04-12 |
2009-02-26 |
Ludwig Institute For Cancer Research, Ltd |
Recombinant anti-interleukin-9 antibodies
|
PT1534335E
(pt)
|
2002-08-14 |
2012-02-28 |
Macrogenics Inc |
Anticorpos específicos de fcγriib e processos para a sua utilização
|
WO2004058147A2
(en)
|
2002-12-16 |
2004-07-15 |
Halozyme, Inc. |
Human chondroitinase glycoprotein (chasegp), process for preparing the same, and pharmaceutical compositions comprising thereof
|
CA2512729C
(en)
|
2003-01-09 |
2014-09-16 |
Macrogenics, Inc. |
Identification and engineering of antibodies with variant fc regions and methods of using same
|
US8021833B2
(en)
|
2003-02-12 |
2011-09-20 |
Functional Genetics, Inc. |
Method for reducing HIV viral budding by administering a VPS28-specfic antibody that disrupts Gag-TSG101-VPS28 binding interactions
|
US7871607B2
(en)
|
2003-03-05 |
2011-01-18 |
Halozyme, Inc. |
Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycanases
|
DK2177620T3
(en)
|
2003-03-05 |
2015-01-26 |
Halozyme Inc |
Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, use and pharmaceutical compositions comprising thereof
|
US20060104968A1
(en)
|
2003-03-05 |
2006-05-18 |
Halozyme, Inc. |
Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminogly ycanases
|
EP1613273B1
(en)
|
2003-04-11 |
2012-06-13 |
MedImmune, LLC |
Recombinant il-9 antibodies and uses thereof
|
WO2004113498A2
(en)
|
2003-06-13 |
2004-12-29 |
University Of Medicine And Dentistry Of New Jersey |
Rna interferases and methods of use thereof
|
CA2532250A1
(en)
|
2003-07-15 |
2005-02-03 |
Barros Research Institute |
Compositions and methods for immunotherapy of cancer and infectious diseases
|
US20050221383A1
(en)
|
2003-08-08 |
2005-10-06 |
Choong-Chin Liew |
Osteoarthritis biomarkers and uses thereof
|
AU2004286198C1
(en)
|
2003-08-18 |
2011-02-24 |
Medimmune, Llc |
Humanization of antibodies
|
WO2005032572A2
(en)
|
2003-10-03 |
2005-04-14 |
Vib Vzw |
Means and methods for the recruitment and identification of stem cells
|
US20050227251A1
(en)
|
2003-10-23 |
2005-10-13 |
Robert Darnell |
Method of purifying RNA binding protein-RNA complexes
|
CA2543954C
(en)
|
2003-10-27 |
2016-11-08 |
Rosetta Inpharmatics Llc |
Method of designing sirnas for gene silencing
|
HUE064610T2
(hu)
|
2003-12-23 |
2024-04-28 |
Genentech Inc |
Új anti-IL 13 antitestek és alkalmazásaik
|
WO2005097184A2
(en)
|
2004-03-26 |
2005-10-20 |
Human Genome Sciences, Inc. |
Antibodies against nogo receptor
|
CN101426489A
(zh)
|
2004-04-16 |
2009-05-06 |
曹义海 |
抑制血管生成的成分和方法
|
EP1747292B1
(en)
|
2004-05-07 |
2015-07-08 |
The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. |
Methods of diagnosing or treating prostate cancer using the erg gene, alone or in combination with other over or under expressed genes in prostate cancer
|
WO2006046994A2
(en)
|
2004-07-30 |
2006-05-04 |
Mount Sinai School Of Medicine Of New York University |
Klf6 alternative splice forms and a germline klf6 dna polymorphism associated with increased cancer risk
|
WO2006047639A2
(en)
|
2004-10-27 |
2006-05-04 |
Medimmune, Inc. |
Modulation of antibody specificity by tailoring the affinity to cognate antigens
|
WO2006055635A2
(en)
|
2004-11-15 |
2006-05-26 |
Mount Sinai School Of Medicine Of New York University |
Compositions and methods for altering wnt autocrine signaling
|
GB0426146D0
(en)
|
2004-11-29 |
2004-12-29 |
Bioxell Spa |
Therapeutic peptides and method
|
NZ556158A
(en)
|
2004-12-22 |
2010-04-30 |
Auckland Uniservices Ltd |
Trefoil factors and methods of treating proliferation disorders using same
|
JP5139083B2
(ja)
|
2005-01-25 |
2013-02-06 |
プロレキシーズ ファーマシューティカルズ インコーポレイテッド |
抗腫瘍剤としてのキノキサリン誘導体
|
EP2520669A3
(en)
|
2005-02-07 |
2013-02-27 |
GeneNews Inc. |
Mild osteoathritis biomarkers and uses thereof
|
CA2602035C
(en)
|
2005-03-18 |
2015-06-16 |
Medimmune, Inc. |
Framework-shuffling of antibodies
|
US9889197B2
(en)
|
2005-04-15 |
2018-02-13 |
Macrogenics, Inc. |
Covalently-associated diabody complexes that possess charged coil domains and that are capable of enhanced binding to serum albumin
|
ES2971647T3
(es)
|
2005-04-15 |
2024-06-06 |
Macrogenics Inc |
Diacuerpos covalentes y usos de los mismos
|
WO2006125141A2
(en)
|
2005-05-17 |
2006-11-23 |
Amicus Therapeutics, Inc. |
A method for the treatment of pompe disease using 1-deoxynojirimycin derivatives
|
WO2007005898A2
(en)
|
2005-07-05 |
2007-01-11 |
Cornell Research Foundation, Inc. |
Blocking leukocyte emigration and inflammation by interfering with cd99l2
|
DK1919503T3
(en)
|
2005-08-10 |
2014-12-15 |
Macrogenics Inc |
Identification and preparation of antibodies with variant fc regions and methods of use thereof
|
TW200730825A
(en)
|
2005-10-21 |
2007-08-16 |
Genenews Inc |
Method and apparatus for correlating levels of biomarker products with disease
|
CA2903896A1
(en)
|
2005-11-04 |
2007-05-18 |
Genentech, Inc. |
Use of complement pathway inhibitors to treat ocular diseases
|
EP2387995A1
(en)
|
2006-03-30 |
2011-11-23 |
PTC Therapeutics, Inc. |
Methods for the production of functional protein from DNA having a nonsense mutation and the treatment of disorders associated therewith
|
HUE030269T2
(en)
|
2006-06-26 |
2017-04-28 |
Macrogenics Inc |
FC RIIB-specific antibodies and methods for their use
|
US7572618B2
(en)
|
2006-06-30 |
2009-08-11 |
Bristol-Myers Squibb Company |
Polynucleotides encoding novel PCSK9 variants
|
KR101374983B1
(ko)
|
2006-08-28 |
2014-03-17 |
라 졸라 인스티튜트 포 앨러지 앤드 이뮤놀로지 |
길항성 인간 light-특이적 인간 모노클로날 항체를 포함하는 제약 조성물
|
US8541169B2
(en)
|
2006-10-10 |
2013-09-24 |
The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. |
Prostate cancer-specific alternations in ERG gene expression and detection and treatment methods based on those alterations
|
WO2008048545A2
(en)
|
2006-10-16 |
2008-04-24 |
Medimmune, Llc. |
Molecules with reduced half-lives, compositions and uses thereof
|
MX2009005026A
(es)
|
2006-11-15 |
2009-07-31 |
Functional Genetics Inc |
Anticuerpos anti-tsg101 y sus usos para tratamiento de infecciones virales.
|
TWI419904B
(zh)
|
2006-12-18 |
2013-12-21 |
Genentech Inc |
拮抗劑抗-notch3抗體及其用於預防及治療notch3相關疾病之用途
|
US8664364B2
(en)
|
2007-01-24 |
2014-03-04 |
Carnegie Mellon University |
Optical biosensors
|
MX2009013816A
(es)
|
2007-06-21 |
2010-02-24 |
Macrogenics Inc |
Diacuerpos covalentes y usos de los mismos.
|
CA2691166A1
(en)
|
2007-06-27 |
2008-12-31 |
Liu Dongxu |
Polypeptides and polynucleotides for artemin and related ligands, and methods of use thereof
|
LT2195023T
(lt)
|
2007-08-29 |
2018-06-25 |
Sanofi |
Humanizuoti anti-cxcr5 antikūnai, jų dariniai ir jų panaudojimas
|
WO2009123894A2
(en)
|
2008-04-02 |
2009-10-08 |
Macrogenics, Inc. |
Her2/neu-specific antibodies and methods of using same
|
EP2252631B1
(en)
|
2008-04-02 |
2016-04-13 |
MacroGenics, Inc. |
Bcr-complex-specific antibodies and methods of using same
|
US7928189B2
(en)
|
2008-05-05 |
2011-04-19 |
Ottawa Health Research Institute |
PCSK9 polypeptide fragment
|
CA2726845C
(en)
|
2008-06-04 |
2017-09-26 |
Macrogenics, Inc. |
Antibodies with altered binding to fcrn and methods of using same
|
KR101432474B1
(ko)
|
2008-09-07 |
2014-08-21 |
글라이코넥스 인코포레이티드 |
항-연장된 ⅰ형 글라이코스핑고지질 항체, 이의 유도체 및 용도
|
WO2010036978A2
(en)
|
2008-09-25 |
2010-04-01 |
Transgenrx, Inc. |
Novel vectors for production of growth hormone
|
WO2010036976A2
(en)
|
2008-09-25 |
2010-04-01 |
Transgenrx, Inc. |
Novel vectors for production of antibodies
|
JP5734201B2
(ja)
|
2008-12-19 |
2015-06-17 |
マクロジェニクス,インコーポレーテッド |
共有結合型ダイアボディ及びその使用
|
EP2367564A1
(en)
|
2008-12-22 |
2011-09-28 |
Universität Regensburg |
Norrin in the treatment of diseases associated with an increased tgf-beta activity
|
WO2010096388A2
(en)
|
2009-02-18 |
2010-08-26 |
Carnegie Mellon University |
Quenched dendrimeric dyes for bright detection
|
WO2010118360A1
(en)
|
2009-04-09 |
2010-10-14 |
The Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College |
Production of proteins using transposon-based vectors
|
EP2424978B1
(en)
|
2009-04-27 |
2018-08-15 |
Ottawa Hospital Research Institute |
Compositions and methods for modulating stem cells and uses thereof
|
WO2010141329A1
(en)
|
2009-06-01 |
2010-12-09 |
Medimmune, Llc |
Molecules with extended half-lives and uses thereof
|
DK2464664T3
(da)
|
2009-08-13 |
2016-01-18 |
Crucell Holland Bv |
Antistoffer mod humant respiratorisk syncytialvirus (rsv) og fremgangsmåder til anvendelse deraf
|
WO2011035205A2
(en)
|
2009-09-18 |
2011-03-24 |
Calmune Corporation |
Antibodies against candida, collections thereof and methods of use
|
WO2011046457A1
(en)
|
2009-10-16 |
2011-04-21 |
Auckland Uniservices Limited |
Anti-neoplastic uses of artemin antagonists
|
WO2011057188A1
(en)
|
2009-11-06 |
2011-05-12 |
Idexx Laboratories, Inc. |
Canine anti-cd20 antibodies
|
US9597346B2
(en)
|
2010-01-15 |
2017-03-21 |
Cornell University |
Methods for reducing protein levels in a cell
|
EP2577309B1
(en)
|
2010-05-25 |
2016-11-23 |
Carnegie Mellon University |
Targeted probes of cellular physiology
|
NZ703035A
(en)
|
2010-07-09 |
2016-06-24 |
Crucell Holland Bv |
Anti-human respiratory syncytial virus (rsv) antibodies and methods of use
|
EP2659271A4
(en)
|
2010-12-27 |
2015-04-08 |
Univ Brown |
THERAPEUTIC AND DIAGNOSTIC PROCEDURES USING BIGLYCAN AND UTROPHINE
|
WO2012162068A2
(en)
|
2011-05-21 |
2012-11-29 |
Macrogenics, Inc. |
Deimmunized serum-binding domains and their use for extending serum half-life
|
ES2690305T3
(es)
|
2011-09-16 |
2018-11-20 |
Ottawa Hospital Research Institute |
Composiciones de Wnt7a y métodos de utilización de las mismas
|
TWI605061B
(zh)
|
2012-02-15 |
2017-11-11 |
諾佛 儂迪克股份有限公司 |
會結合及阻斷表現在骨髓細胞上觸發受體-1(trem-1)之抗體
|
US9550830B2
(en)
|
2012-02-15 |
2017-01-24 |
Novo Nordisk A/S |
Antibodies that bind and block triggering receptor expressed on myeloid cells-1 (TREM-1)
|
JP6400480B2
(ja)
|
2012-02-15 |
2018-10-03 |
ノヴォ ノルディスク アー/エス |
ペプチドグリカン認識タンパク質1に結合する抗体
|
US9592289B2
(en)
|
2012-03-26 |
2017-03-14 |
Sanofi |
Stable IgG4 based binding agent formulations
|
CA2877441A1
(en)
|
2012-07-02 |
2014-01-09 |
Medizinische Universitat Wien |
Complement split product c4d for the treatment of inflammatory conditions
|
WO2014120975A1
(en)
|
2013-02-01 |
2014-08-07 |
California Institute Of Technology |
Antibody-mediated immunocontraception
|
EP3110974A4
(en)
|
2014-02-24 |
2018-01-24 |
Celgene Corporation |
Methods of using an activator of cereblon for neural cell expansion and the treatment of central nervous system disorders
|
JP6832709B2
(ja)
|
2014-05-16 |
2021-02-24 |
メディミューン,エルエルシー |
新生児Fc受容体結合が改変されて治療および診断特性が強化された分子
|
US9458464B2
(en)
|
2014-06-23 |
2016-10-04 |
The Johns Hopkins University |
Treatment of neuropathic pain
|
KR102641268B1
(ko)
|
2014-07-17 |
2024-02-27 |
노보 노르디스크 에이/에스 |
점도를 감소시키기 위한 trem-1 항체의 부위 지정 돌연변이유발
|
US10434177B2
(en)
|
2014-11-17 |
2019-10-08 |
Carnegie Mellon University |
Activatable two-component photosensitizers
|
WO2016191418A1
(en)
|
2015-05-26 |
2016-12-01 |
Salk Institute For Biological Studies |
Motor neuron-specific expression vectors
|
US20190145961A1
(en)
|
2016-04-20 |
2019-05-16 |
Washington University |
Ppar agonist or lxr agonist for use in the treatment of systemic lupus erythematosus by modulation of lap activity
|
KR20200139219A
(ko)
|
2018-04-02 |
2020-12-11 |
브리스톨-마이어스 스큅 컴퍼니 |
항-trem-1 항체 및 이의 용도
|
KR20230135586A
(ko)
|
2021-01-24 |
2023-09-25 |
마이클 데이비드 포레스트 |
Atp 합성효소 억제제 - 미용 및 치료 용도
|
WO2023131901A1
(en)
|
2022-01-07 |
2023-07-13 |
Johnson & Johnson Enterprise Innovation Inc. |
Materials and methods of il-1beta binding proteins
|
WO2024013727A1
(en)
|
2022-07-15 |
2024-01-18 |
Janssen Biotech, Inc. |
Material and methods for improved bioengineered pairing of antigen-binding variable regions
|